Daily Stock List
AmpliTech Group, Inc. (AMPG)
AllPennyStocks, SmallCapVoice, PennyStocks24, Information Solutions Group, Pumps and Dumps, and Trading Wall St reported earlier on AmpliTech Group, Inc. (AMPG), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
AmpliTech Group, Inc. designs, develops, and manufactures custom and standard state-of-the-art RF Low Noise Amplifiers (LNA) and Power Amplifiers (PA). These are for the domestic and international, SATCOM, Space, and Military markets. Additionally, the Company provides consulting services to help with any microwave components or systems design problems. AmpliTech sells its products via sales representatives and distributors in North America, Europe, and Asia. OTCQB listed, the Company has its headquarters in Bohemia, New York.
Mr. Fawad Maqbool founded AmpliTech Group to fill the need for high quality, reliable, state-of-the-art, RF components at an affordable cost, with fast deliveries, and trouble-free customer service. Mr. Maqbool has over 20 years of experience in the design of microwave amplifiers and components.
AmpliTech provides its customers with consulting services for their system development. As well, it provides technical assistance in integration and packaging technologies and also microwave sub-systems and amplifier related sub-assemblies.
The Company utilizes the most contemporary CAD microwave simulation technology to design and develop from concept to final manufacture of a deliverable product with first-rate accuracy. AmpliTech expects to release new products targeted at the wireless and satellite markets that will provide state-of-the-art technology and performance.
AmpliTech’s designs cover the frequency spectrum from 50 kHz to 40 GHz - eventually, providing designs up to 100 GHz. It can provide complex, custom solutions for almost any custom requirements presented to it. AmpliTech can provide contract assembly of customers' own designs.
Last month, AmpliTech announced the receipt of $403,000 of orders in fiscal Q2 2016 and more than $700,000 in the month of July 2016. Furthermore, AmpliTech is continuing efforts to partner with key original equipment manufacturers (OEM's) to provide superior products for microwave communication and wireless markets. It stated that these efforts will expand its reach into fast growing sectors of the industry, and increase its market share in existing and new business platforms.
Last week, AmpliTech announced its Fiscal Q2. The Company produced record revenues of $504,656, and generated EBIT (Earnings Before Interest and Taxes) of approximately $160,000. This represents an almost 8-fold increase over the same quarter of 2015, considerably growing its available cash and flexibility for business development.
AmpliTech Group, Inc. (AMPG), closed Wednesday's trading session at $0.041, up 0.24%, on 9,000 volume with 1 trade. The average volume for the last 60 days is 123,320 and the stock's 52-week low/high is $0.012/$0.0419.
Major League Football, Inc. (MLFB)
TopPennyStockMovers, Stock News Now, and SmallCapVoice reported previously on Major League Football, Inc. (MLFB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Major League Football, Inc. is a new, professional spring-football league. The Company’s shares began trading on the OTC Markets Group’s OTCQB on September 16, 2015. The Company formerly went by the name Universal Capital Management, Inc. It changed its corporate name to Major League Football, Inc. in November 2014.
The Company’s plan is to establish franchises and provide fans with professional football in the National Football League off-seasons. Major League Football is based in Lakewood Ranch, Florida.
Its dedication is to creating a ground-breaking, accessible, and fan-owned game. The teams of the league will concentrate on emerging markets in select U.S. cities to grow the overall popularity of the sport. Major League Football is considering in excess of 14 new markets as potential cities the league will further review to set the number of teams in its inaugural season.
In September 2015, Major League Football announced that it started finalizing potential host venues across the nation to establish cities that will become the inaugural season team sites. The Company is confirming its plans based on the earlier round of financing acquired by the league and additional investor interest.
Major League Football said that it will review the venues in cities earlier announced, evaluate fan appeal, local business support and other criteria. This is to reconfirm cities and their venues best suited for the league's inaugural kick off.
On April 1, 2016, Major League Football announced the League would launch a "Development Season" this year and reschedule its inaugural year of professional, spring-league football to March of 2017. Company management, coaches, player representatives and the League's business partners agreed to use the present season to further develop players, plan for staffing in cities, as well as provide plenty of time for ticketing agencies and the League's broadcasting partner to advertise and market the League's formal kick-off next year.
Major League Football, Inc. (MLFB), closed Wednesday's trading session at $0.26, down 3.70%, on 63,236 volume with 24 trades. The average volume for the last 60 days is 26,638 and the stock's 52-week low/high is $0.101/$1.72.
Zynex, Inc. (ZYXI)
BUYINS.NET, TaglichBrothers, Zacks, SmarTrend Newsletters, FeedBlitz, FNNO Newsletters, Daily Markets, and SmallCapVoice reported previously on Zynex, Inc. (ZYXI), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Established in 1996, Zynex, Inc. is a medical technology company headquartered in Lone Tree, Colorado. It specializes in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neuro diagnostics, cardiac and blood volume monitoring. In addition, the Company is developing a new blood volume monitor for use in hospitals and surgery centers.
Zynex markets and sells its own design of electrotherapy medical devices utilized for pain management and rehabilitation; and its proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Its product lines are fully developed, Food and Drug Administration (FDA)-cleared, and commercially sold worldwide.
Zynex engineers, manufactures, markets and sells its own design of medical devices in three subsidiaries. Zynex Medical is a provider of electrotherapy products for home use. Zynex Monitoring Solutions develops products for cardiac monitoring for use in hospitals. Zynex NeuroDiagnostics develops devices for EMG and EEG diagnostic purposes in the neurology clinic markets.
In March 2015, Zynex announced that it submitted a Pre-Submission application to the FDA for its non-invasive Blood Volume Monitor, CM-1500. The Company’s belief is that this will be the first device to provide an indication of fluid balance and blood loss in the operating room or potential post-surgical internal bleeding in recovery.
In September 2015, Zynex announced that its wholly-owned subsidiary, Zynex Monitoring Solutions, filed an application with the FDA pursuant to Section 510(k) of the Food, Drug and Cosmetic Act for clearance of its new CM-1500 monitoring device.
Last week, Zynex announced July 2016 electrotherapy orders. The Company received 1,912 orders during the month of July. This is 104 percent more than the 937 orders received in July of last year and 8 percent less than June orders.
This week, Zynex announced its Q2 2016 financial results. Zynex President and Chief Executive Officer, Mr. Thomas Sandgaard, said, "Revenue came in at $3.3 million, 7 percent above the second quarter last year. We came closer to a breakeven result with a net loss of $227,000, a significant improvement compared with the second quarter 2015 loss of $501,000.”
Zynex, Inc. (ZYXI), closed Wednesday's trading session at $0.25, up 4.17%, on 8,900 volume with 5 trades. The average volume for the last 60 days is 4,838 and the stock's 52-week low/high is $0.10/$0.453.
BioSig Technologies, Inc. (BSGM)
SeeThruEquityResearch, DreamTeamNetwork, BUYINS.NET, Stock News Now, Goldman Small Cap Research, PennyStockLocks.com, ResearchOTC, StockRockandRoll, and Wall Street Resources reported on BioSig Technologies, Inc. (BSGM), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
BioSig Technologies, Inc. is a medical device company developing PURE EP™ - a proprietary technology platform designed to improve the clinical outcomes of electrophysiology (EP) procedures. The Company’s aim is to seek Food and Drug Administration (FDA) 510(k) approval for the PURE EP™ System. It is preparing to commercialize the PURE EP™ System. OTCQB listed, BioSig Technologies has an office in Los Angeles, California focused on research and development (R&D). BioSig Technologies has its headquarters in Minneapolis, Minnesota.
BioSig Technologies’ PURE EP™ is a next-generation surface electrocardiogram and intracardiac multichannel signal acquisition and analysis system. The design of it is to help electrophysiologists in making clinical decisions in real-time through acquiring and displaying high-fidelity cardiac signal recordings and providing clarity of data that may be used to guide the electrophysiologists in identifying ablation targets (areas of tissue to treat that otherwise create a heart rhythm disturbance (arrhythmia)).
BioSig Technologies has attained proof of concept validation and tested its prototype at the University of California at Los Angeles (UCLA) Cardiac Arrhythmia Center. It has performed pre-clinical studies at Mayo Clinic in Minnesota. Moreover, BioSig is collaborating with other prestigious cardiac arrhythmia centers. These include Texas Cardiac Arrhythmia Institute, UH Case Medical Center in Cleveland, Ohio, and Mount Sinai Medical Center in New York.
BioSig Technologies has signed a Sponsored Research Agreement with The Regents of The University of California at Los Angeles (UCLA) to conduct preclinical evaluation of the Company’s PURE EP™ System in a ventricular tachycardia (VT) model. The studies will center on intracardiac and percutaneous epicardial mapping utilizing the PURE EP information system to explore the complex scar architecture that typically supports multiple morphologies of VT.
BioSig plans to transition from pre-clinical evaluation of the PURE EP to product development. It expects to fully develop a Quality Management System. The Company has partnered with Minnetronix on technology development. BioSig is working toward an FDA 510(k) clearance for the PURE EP System.
Company Management announced a new Advanced Research Initiative with Mayo Clinic based on the success of preclinical trials throughout 2015. Nine more trials have been scheduled through Q2 2017. The design of this program is to build upon the initial studies conducted at the Mayo Clinic in March, June, and November 2015 through a tripling of investment to fully characterize and develop novel features discovered during this prior preclinical work. Bio Sig states that these features have the potential to make a significant impact in the treatment of complex arrhythmias.
This month, BioSig Technologies announced that the Journal of the American College of Cardiology: Clinical Electrophysiology published an article entitled "Novel Electrophysiology Signal Recording System Enables Specific Visualization of the Purkinje Network and Other High-Frequency Signals" by Ammar M. Killu, MBBS, Niyada Naksuk, MD, Kalpathi L. Venkatachalam, MD, and Samuel J. Asirvatham, MD from Mayo Clinic. The Clinical Electrophysiology Publication highlights PURE EP's unique ability to visualize high frequency signals.
BioSig Technologies, Inc. (BSGM), closed Wednesday's trading session at $1.35, up 3.05%, on 22,029 volume with 40 trades. The average volume for the last 60 days is 30,425 and the stock's 52-week low/high is $0.90/$2.20.
Avant Diagnostics, Inc. (AVDX)
SeeThruEquityResearch, DreamTeamNetwork, StocksToBuyNow and Tip.us reported earlier on Avant Diagnostics, Inc. (AVDX), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.
Avant Diagnostics, Inc. is a molecular diagnostics company with its corporate headquarters in Scottsdale, Arizona. It specializes in biomarker tests undergoing development in the areas of oncology and neurology. The Company is developing specialized tests, which are pioneering in medical testing. Moreover, its OvaDx® Pre-Symptomatic Ovarian Cancer Screening Test is a leading innovation in commercializing these tests. Avant Diagnostics’ shares trade on the OTC Markets’ OTCQB.
Avant Diagnostics is the leading developer of proteomic technologies for measuring the activation status of key signaling pathways across many different cancer types, including breast, ovarian, and pancreatic, which are instrumental in the development of companion diagnostics for molecular-targeted therapies.
The Company has patented its manufacturing technology and its OvaDx® markers and kits are proprietary. In addition, Avant is developing OvaDx® for use in monitoring women diagnosed previously with ovarian cancer. OvaDx® is a sophisticated microarray-based test. OvaDx® measures the activation of the immune system in blood samples in response to ovarian tumor cell development.
Avant provides personalized medicine diagnostic testing capabilities by way of its TheraLink® Diagnostic Assays, primarily for breast cancer, to assist clinical oncologists in identifying likely responders for around 30 Food and Drug Administration (FDA)-approved drug treatment regimens through its CLIA/CAP.
Avant Diagnostics has its neurology division, which owns the rights to MSPrecise™, a proprietary next-generation DNA sequencing (NGS) assay for the identification of patients with relapsing-remitting multiple sclerosis (RRMS) at first clinical presentation; has an exclusive worldwide license to the Lymphocyte Proliferation test (LymPro Test™) for Alzheimer's disease, developed by Prof. Thomas Arendt, Ph.D., from the University of Leipzig; and owns intellectual property (IP) for the diagnosis of Parkinson's disease (NuroPro).
Avant Diagnostics earlier announced it completed the acquisition of Amarantus Diagnostics, Inc. (AMDX), a wholly-owned subsidiary of Amarantus BioScience Holdings, Inc. (AMBS), and the business of Theranostics Health, Inc. (THI). With the agreement for the acquisition of AMDX, Avant Diagnostics acquired all of the outstanding shares of common stock of AMDX for 80,000,000 shares of Avant Diagnostics common stock, subject to issuance of additional shares upon the occurrence of certain future events. With the agreement for the acquisition of THI, Avant acquired the assets and operations of THI for 25,000,000 shares of Avant Diagnostics common stock.
This past June, Avant Diagnostics announced that Dr. Vince Picozzi presented data on use of the Company’s TheraLink® assay in pancreatic cancer at the International Symposium on Pancreas Cancer 2016.
Mr. Glenn Hoke, PhD, incoming Chief Scientific Officer at Avant Diagnostics, said, “The presentation of data by D. Picozzi demonstrating that information on the activation status of signaling pathways, as provided by the technology behind our TheraLink® tests, prior to adjuvant therapy could enhance current prognostic models and/or identify new pharmacological targets is an important step forward as we validate additional applications for TheraLink® beyond breast cancer.”
Avant Diagnostics, Inc. (AVDX), closed Wednesday's trading session at $0.2599, up 8.29%, on 8,783 volume with 7 trades. The average volume for the last 60 days is 11,920 and the stock's 52-week low/high is $0.11/$0.7241.
Monaker Group, Inc. (MKGI)
The QualityStocks Daily Newsletter would like to spotlight Monaker Group, Inc. (MKGI). Today, Monaker Group, Inc. closed trading at $4.14, off by 2.36%, on 18,959 volume with 32 trades. The stock’s average daily volume over the past 60 days is 7,834, and its 52-week low/high is $1.10/$5.00.
Monaker Group, Inc. announced today that it has completed the design, architecture and buildout of the Monaker Booking Engine ("MBE") and the Application Program Interface ("API") is complete. The completion of the API and corresponding launch of the MBE allows Monaker to work towards partnering with large established Online Travel Agencies, tour operators, airline and cruise originators.
Monaker Group, Inc. (MKGI) is a technology driven travel company focused on leveraging resources to become a significant presence in the fastest growing sector of the $1.3 trillion travel and tourism market. The company's flagship brand, NextTrip.com, is the industry's first and only real-time booking engine that features alternative lodging (vacation home rentals, resort residences and unused timeshare inventory), as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. These features are combined into a single, easy-to-use platform that gives travelers complete real-time control when planning and booking their vacations.
NextTrip.com takes an integrated approach to the needs of travelers by combining multiple booking solutions into a highly intuitive real-time booking platform. Since its launch in February 2016, NextTrip has already grown to more than 250,000 units of vacation rental inventory. Monaker currently has roughly 1 million additional alternative lodging units under contract that will soon be added to the platform. This will place NextTrip among the top three largest vacation rental inventories and rival industry peers, Airbnb and HomeAway, in the rapidly expanding alternative lodging market. Unlike the competition, which book by request which can take hours or days before a lodging owner confirms, NextTrip's platform books in real-time, similar to online hotel bookings.
Most NextTrip listings are in desirable locations in the U.S., the EU and the Caribbean with about 20% exclusive listings. Monaker expects rapid exclusive listing growth because, unlike the competition, Monaker doesn't charge a sign-up fee, just a commission upon booking. The competition charges both. Monaker even has a proprietary solution to unlock Timeshare and Fractional Share properties as rental inventory.
Through strategic partnerships and acquisitions Monaker is now positioned to be a major player in the travel and alternative lodging sector. In addition Monaker is also the parent to Maupintour and Voyage TV.
In business for 65 years, Maupintour still leads the tour industry in the creation of outstanding, unique itineraries and has the highest repeat rate in the tour industry. Maupintour's upscale luxury services create a unique blend with the various product offerings of NextTrip. Voyage TV has thousands of hours of travel footage shot in over 30 countries worldwide. These 15,000 video clips of hotels, resorts, cruise, and destination activities are a treasure trove for vacation travel marketing.
With an established portfolio of travel brands, and a proven record acquiring, consolidating and integrating companies, Monaker is building a diverse and exciting foundation to drive the company's future. According to data from the U.S. Travel Association, direct spending on leisure travel by domestic and international travelers topped $650 billion in 2015. When combined with the fact that roughly 64 percent of travel companies are still considered small businesses, Monaker's all-inclusive approach to vacation booking through NextTrip and Maupintour strategically positions it for sustainable growth moving forward.
Monaker is headquartered in South Florida with offices in California. The company is led by a seasoned management team with decades of applicable industry experience. Monaker's Chairman and Chief Executive Officer Bill Kerby has over 18 years of experience in the media and travel industries, as well as 10 years of experience in the financial industry. Disclaimer
Monaker Group, Inc. Company Blog
Monaker Group, Inc. News:
Monaker Group Achieves Key Milestone - Application Program Interface (API) and Booking Engine Complete
Monaker Launches Premium Service for Alternative Lodging Listings
Monaker Group Announces Agreement with Trisept Solutions
OurPet's Company (OPCO)
The QualityStocks Daily Newsletter would like to spotlight OurPet's Company (OPCO). Today, OurPet's Company closed trading at $0.81, up 2.53%, on 400 volume with 2 trades. The stock’s average daily volume over the past 60 days is 4,335, and its 52-week low/high is $0.631/$1.06.
OurPet's Company (OPCO) develops, produces and markets various pet accessory and consumable products designed to awaken pets' natural instincts, be it in feeding, playing or waste management. Sold globally through pet specialty retailers, food, drug and mass chains, e-commerce and international channels, the company's products are marketed under a the OurPets®, Pet Zone® and PetTastic® brands with well-known sub-brands such as Play-N-Squeak™, Cosmic Catnip™, Durapet, SmartScoop and Flappy. In total, OurPet's has an intellectual property portfolio featuring more than 160 individual patents, giving the company sustainable access to the pet products industry for the foreseeable future.
In recent years, the U.S. pet products and services market has experienced strong growth, with total sales accounting for approximately $73 billion in 2014, according to a report by Packaged Facts. In 2015, this strong performance is expected to continue, building on the recent rise in related ecommerce purchases, as well as an uptick in dog and cat ownership throughout the country. In order to capitalize on this market performance, OurPet's maintains an ongoing new product development program to continually keep an evolutionary and revolutionary new product pipeline feeding its offerings. In July 2015, OurPet's introduced many new products at the national Super Zoo trade show in Las Vegas such as the Catty Whack®, Designer Diner™/Barking Bistro™ and the Zoom Plume™.
The company's capitalization strategy is guided by a management team of experienced industry professionals dedicated to further strengthening its product portfolio through aggressive development of innovative products. Management has a proven track-record of leveraging deep knowledge in the innovation, technology, distribution and pet markets to successfully push through adverse market conditions to achieve increases in revenue, margins and net income.
OurPet's, through its innovative and extensive line of popular pet products, is in a favorable strategic position to continue building upon its recent market growth. For prospective shareholders, this positioning makes the company an intriguing investment opportunity in the months to come. Look for OurPet's to capitalize on steady market performance moving forward, providing an opportunity for the company to realize strong investor returns in the future. Disclaimer
OurPet's Company Company Blog
OurPet's Company News:
OurPet’s Company Reports Results for 2016 Second Quarter
OurPet's Company (OPCO) Has a New Natural Solution to Your Cat Litter Woes
OurPet's Company Now Licensing Polymer Bonded Pet Bowl Patent
Moxian, Inc. (MOXC)
The QualityStocks Daily Newsletter would like to spotlight Moxian, Inc. (MOXC). Today, Moxian, Inc. closed trading at $5.90, off by 0.84%, on 100 volume with 1 trade. The stock’s average daily volume over the past 60 days is 44, and its 52-week low/high is $5.80/$13.00.
Moxian, Inc. (MOXC) engages in the business of providing social marketing and promotion platforms designed to help merchants accelerate and advertise their business growth through social media. These products and services enable merchants to run targeted advertising campaigns and promotions, and aim to enhance the interaction between users and merchant clients by using consumer behavior data compiled from the Moxian database of user activities. The company has two primary core products: Moxian+ User App and Moxian+ Business App.
Developed in Shenzhen, China, Moxian integrates social media, entertainment and business intelligence. The Multi-Channel Social Commerce Platform, which includes a variety of tools such as Moxian's proprietary Social Customer Relationship Management (SCRM) system, generates knowledgeable data for merchants. This way, consumers and businesses are able to connect and interact with one another to achieve the concept of "online lifestyle, offline fun."
Moxian+ User App serves as an App driven for consumer users to use the platform, consisting of our proprietary virtual currency (MO-Coin and MO-Points), social networking, redemption centre and game centre. Users can earn MO-Coins by playing games, and then use those coins to redeem prizes sponsored by Moxian and client merchants. This model not only drives registered consumers to Moxian and merchant, but also provides merchants the opportunity to advertise, run marketing campaigns, and learn about their customers through the Platform.
Moxian+ Business App is an independent App with built in Social Customer Relationship Management tool built for merchants. Merchants are able to set up a store on the Moxian platform through this business App, push promotions via a variety of methods offered on the platform and look at generated report customized to their own shop.
Moxian's management team has more than 100 years of combined experience in a variety of pertinent endeavors, including management of private and public enterprise, multi-national organizations, quality, engineering and procurement, finance, marketing, communication and more. Together, Moxian's management team is effecting the company's aim to create and lead a personalized social network platform that best fits users and businesses. Disclaimer
Moxian, Inc. Company Blog
Moxian, Inc. News:
Moxian Adopts Oracle Database Solutions to Support the Latest Payment and Transaction Platform, Enabling Intelligent Big Data
Moxian Enters Into Exclusive Agreement and Development Partnership With Xinhua Media Affiliate
Moxian, Inc. Covered by Crystal Equity Research
Agora Holdings, Inc. (AGHI)
The QualityStocks Daily Newsletter would like to spotlight Agora Holdings, Inc. (AGHI). Today, Agora Holdings, Inc. closed trading at $0.11, off by 15.38%, on 101,850 volume with 19 trades. The stock’s average daily volume over the past 60 days is 24,884, and its 52-week low/high is $0.03/$0.7999.
Agora Holdings, Inc. (AGHI), together with its wholly-owned subsidiary, Geegle Media, is leading a diversified family entertainment and media enterprise through business segments which include: TV on Demand, interactive media, business products and consumer platforms. With its multi-dimensional approach, Geegle Media supports Agora Holdings' mission to deliver innovate and high-quality business solution products and to deliver video content from around the world.
Geegle Media web platforms include; GeegleTV, Frame, 1000Salads, RealtyTV and LobbyTV. Geegle TV is a multi-platform video entertainment website that curates high-quality video content from around the world. In 2016, GeegleTV will serve as co-producer by airing original content. By exposing undiscovered content to millions of users and rendering it shareable to social media, Geegle TV will serve as a marketing partner to local and internationally based TV shows not yet on the open market.
For commercial use, Geegle Media provides a variety of solutions that include web development and billing software for VoIP applications. RealtyTV is its state-of-the-art platform for real estate brokerages. LobbyTV is another of its widely used products by business offices. For individuals, Geegle TV combines radio, On Demand movies, news, sports and children's content.
Geegle Media is also developing 1000salads, an online hub that encourages healthy lifestyles. The portal will feature recipes and products, health-oriented articles and a curated selection of local restaurants and grocers that deliver to the health-conscious user. Currently in its alpha stage of development, 1000salads is gearing up its sales and marketing in preparation for its launch in 2016.
Geegle Media differs from other On Demand providers, such as Netflix and HBO, in that its service is free of constraints such as subscription, fees and penalties. As consumers increasingly opt for personalized sources of entertainment, Agora recognizes the vast opportunities and growth potential provided by the rising popularity of TV On Demand. The company also benefits from strong and visionary management with a track record of bringing innovative ideas to fruition. Disclaimer
Agora Holdings, Inc. Company Blog
Agora Holdings, Inc. News:
Agora Holdings Inc. Audit Is Complete, Company Continuing to Progress Its Plans to Move Up the Board to QB Level
Agora Holdings, Inc. Updates Shareholders on FRAME Technology, Accounting Audit
Agora Holdings Inc. Signs Engagement Letter With Auditing Firm, BF Borgers CPA PC
Alternet Systems, Inc. (ALYI)
The QualityStocks Daily Newsletter would like to spotlight Alternet Systems, Inc. (ALYI). Today, Alternet Systems, Inc. closed trading at $0.00454, even for the day. The stock’s average daily volume over the past 60 days is 79,877, and its 52-week low/high is $0.0021/$0.029.
Alternet Systems, Inc. (ALYI) invests in and partners with companies that are creating the future of money in the high growth, emerging technology fields of digital commerce, multichannel payments, and predictive analytics.
Vision: Be the leading digital commerce, multichannel payments, predictive analytics solutions provider into global markets
Mission: To provide innovative solutions that facilitates and expedites commerce, enriching our partners and their customers' experience, and improving efficiency. Recognizing that the world is becoming increasingly dependent on technological conveniences, Alternet Systems aims to provide its customers with the tools to prepare themselves for a new era of digital commerce and payments, financial services and consumer information, and, most importantly, a new era of how to live.
Since 2010, Alternet has maintained a progressive focus on the high-growth, mobile value-added service industries of mobile financial services and mobile security. In 2014, the company expanded its scope of expertise to include in its investment verticals the exciting digital commerce space, transforming the legacy electronic payments infrastructure and developing advanced predictive data analytics applications for the mass consumer, telecommunications and financial industry.
With strategic investments in these three key, high-growth markets, Alternet is accelerating the future of money and its role in the global demand for these services. The company is guided by a team of executives specializing in entrepreneurial endeavors, innovation, corporate strategy, financial and executive management of multi-national organizations, and a vast network of industry resources.
As Alternet embarks on this new path, the company will be led by a management team and board of directors with over a century's worth of combined experience in the fields of investing, technology, and financing, and the consensus knowledge of where to invest and when in start-up and early-stage companies. Disclaimer
Alternet Systems, Inc. Company Blog
Alternet Systems, Inc. News:
Alternet Systems Data Analytics Solution Gains Momentum with New Clients and Partners
Alternet Systems Announces Caprock Research Report with Near Term Price Target of $0.05 and 'Accumulate' Recommendation
Alternet Systems Launches Data Analytics Division To Build On Existing Revenue Base
Today's Top 3
Profitable Trader Authority
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Agora Holdings, Inc. (AGHI) Audit Is Complete, Company Continuing to Progress Its Plans to Move Up the Board to QB Level
- Alternet Systems (ALYI) Data Analytics Solution Gains Momentum with New Clients and Partners
- Cherubim Interests, Inc. (CHIT) Signs Distribution Agreement With XWALLS Inc.
- Dominovas Energy Corp. (DNRG) Set to Deliver Its Rubicon Showcase
- eXp World Holdings, Inc. (EXPI) Fundamental Research Corp. Updates Its Coverage of eXp World Holdings
- Giggles N' Hugs, Inc. (GIGL) engages Kiddos, Inc. and Michelle Steinberg of dOMAIN Integrated to Launch New Marketing and PR Initiatives
- International Stem Cell Corp. (ISCO) Announces Operating Results for the Three and Six-Months Ended June 30, 2016
- Laguna Blends Inc. (LAGBF) Naturally Splendid Provides Update on Laguna’s Pro369 Hemp Protein Growth and Pro Athlete Brand Strategy
- Monaker Group, Inc. (MKGI) Achieves Key Milestone - Application Program Interface (API) and Booking Engine Complete
- Moxian, Inc. (MOXC) Adopts Oracle Database Solutions to Support the Latest Payment and Transaction Platform, Enabling Intelligent Big Data
- OurPet's Company (OPCO) Has a New Natural Solution to Your Cat Litter Woes
- Singlepoint, Inc. (SING) to Capitalize on the Multi-Million Dollar 'Pokemon Go' Phenomenon With Custom Mobile Application
- Star Mountain Resources Inc. (SMRS) Subsidiary Secures $500,000 Loan From a New York Public Benefit Trust
- WRIT Media Group, Inc. (WRIT) Announces New Funding Round